Cyclic peptide antifungal agents
AssigneeEli Lilly and Company
InventorsLisa M. H. LaGrandeur, Michael J. Rodriguez, Mark J. Zweifel
Life of this patent
Estimating the term…
Abstract
Provided are pharmaceutical formulations, and methods of inhibiting fungal and parasitic activity using a compound of formula I ##STR1## where: R', R", R'", R.sup.x1, R.sup.x2, R.sup.y1, R.sup.y2, R.sup.y3, R.sup.y4, and R.sup.0 are as defined hereinabove; and R.sup.2 is ##STR2## R.sup.3 is ##STR3## R.sup.3a is C.sub.1 -C.sub.6 alkyl or C.sub.1 -C.sub.6 alkoxy; R.sup.3b and R.sup.3c are independently phenyl or naphthyl; R.sup.3d is C.sub.1 -C.sub.12 alkyl, C.sub.1 -C.sub.12 alkoxy or --O --(CH.sub.2).sub.m -[O--(CH.sub.2).sub.n ].sub.p --O--(C.sub.1 -C.sub.12 alkyl); m is 2, 3 or 4; n is 2, 3 or 4; p is 0 or 1; or a pharmaceutically acceptable salt thereof.
Claims36
A compound of the formula:
- ##STR35## wherein:
- R' is hydrogen, methyl or NH.sub.2 C(O)CH.sub.2 --;
- R" and R'" are independently methyl or hydrogen;
- R.sup.x1 is hydrogen, hydroxy or --O--R;
- R is C.sub.1 -C.sub.6 alkyl, benzyl, --(CH.sub.2).sub.2 Si(CH.sub.3).sub.3, --CH.sub.2 CHOHCH.sub.2 OH, --CH.sub.2 CH.dbd.CH.sub.2, --(CH.sub.2).sub.a COOH, --(CH.sub.2).sub.b NR.sup.z1 R.sup.z2, --(CH.sub.2).sub.c POR.sup.z3 R.sup.z4 or --[(CH.sub.2).sub.2 O].sub.d --(C.sub.1 -C.sub.6)alkyl;
- a, b and c are independently 1, 2, 3, 4, 5 or 6;
- R.sup.z1 and R.sup.z2 are independently hydrogen, C.sub.1 -C.sub.6 alkyl, or R.sup.z1 and R.sup.z2 combine to form-CH.sub.2 (CH.sub.2)eCH.sub.2 --;
- R.sup.z3 and R.sup.z4 are independently hydroxy or C.sub.1 -C.sub.6 alkoxy;
- d is 1 or 2;
- e is 1, 2 or 3;
- R.sup.x2, R.sup.y1, R.sup.y2, R.sup.y3 and R.sup.y4 are independently hydrogen or hydroxy;
- R.sup.0 is hydroxy, --OP(O)(OH).sub.2 or a group of the formulae:
- ##STR36## R.sup.1 is C.sub.1 -C.sub.6 alkyl, phenyl, p-halo-phenyl, p-nitrophenyl, benzyl, p-halo-benzyl or p-nitro-benzyl;
- R.sup.2 is ##STR37## R.sup.3 is ##STR38## R.sup.3a is C.sub.1 -C.sub.6 alkoxy;
- R.sup.3b and R.sup.3c are independently phenyl or naphthyl;
- R.sup.3d is C.sub.1 -C.sub.12 alkyl, C.sub.1 -C.sub.12 alkoxy or --O--(CH.sub.2).sub.m --[O--(CH.sub.2).sub.n ].sub.p --O--(C.sub.1 -C.sub.12 alkyl);
- m is 2, 3 or 4;
- n is 2, 3 or 4;
- and
- p is 0 or 1;
- or a pharmaceutically acceptable salt thereof.
A method for treating or preventing the onset of Pneumocystis pneumonia in a host susceptible to Pneumocystis pneumonia which comprises administering an effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, to a host in need of such treatment.
Dependencies are inferred from the claim text.